ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,459Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 780

$1.99M Total Retail Price of All Prescriptions

Rank: 5 out of 780

1,164 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 1,164 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 1,164 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 29,038 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,579 1,233 1 2
HYDROCODONE-ACETAMINOPHEN 1,491 921 S3 2 1
FUROSEMIDE 1,255 1,112 3 7
OMEPRAZOLE 1,107 875 4 3
AMLODIPINE BESYLATE 902 691 5 4
LEVOTHYROXINE SODIUM 872 776 6 5
POTASSIUM CHLORIDE 765 632 7 11
METFORMIN HCL 678 471 8 8
NAMENDA 650 583 9 46
WARFARIN SODIUM 579 461 10 24
GABAPENTIN 574 448 11 13
CITALOPRAM HBR 469 388 12 23
CARVEDILOL 462 344 13 14
DONEPEZIL HCL 459 442 14 31
LISINOPRIL 448 396 15 6
PANTOPRAZOLE SODIUM 439 379 16 25
EXELON 422 380 17 132
HYDROCHLOROTHIAZIDE 394 291 18 10
TRAMADOL HCL 389 327 19 15
LANTUS 388 264 20 71
ESCITALOPRAM OXALATE 387 303 21 61
QUETIAPINE FUMARATE 376 323 22 81
ENALAPRIL MALEATE 364 271 23 64
NOVOLIN R 360 274 24 212
TRAZODONE HCL 349 289 25 35
MELOXICAM 345 239 26 16
MIRTAZAPINE 345 317 26 58
POLYETHYLENE GLYCOL 3350 335 293 28 79
SERTRALINE HCL 328 244 29 27
FAMOTIDINE 310 256 30 86
METOPROLOL TARTRATE 309 277 31 19
DIVALPROEX SODIUM 286 218 32 119
CLOPIDOGREL 270 208 33 34
MUPIROCIN 257 176 34 173
FENTANYL 248 193 S2 35 107
PRAVASTATIN SODIUM 242 181 36 9
ALBUTEROL SULFATE 234 219 37 163
CLONIDINE HCL 232 169 38 28
FLUTICASONE PROPIONATE 227 166 39 41
DIGOXIN 222 195 40 56
ZOLPIDEM TARTRATE 219 166 41 17
HUMULIN R 214 174 42 228
RISPERIDONE 214 201 42 98
GLIMEPIRIDE 208 106 44 30
TAMSULOSIN HCL 207 180 45 36
ATENOLOL 206 185 46 21
ROPINIROLE HCL 205 172 47 87
METOPROLOL SUCCINATE 200 166 48 20
PLAVIX 195 155 49 45
IPRATROPIUM BROMIDE 182 171 50 238
LOSARTAN POTASSIUM 182 131 50 18
CRESTOR 181 107 52 32
PROMETHAZINE HCL 179 76 R 53 66
ALLOPURINOL 173 147 54 29
NEXIUM 167 101 55 22
ATORVASTATIN CALCIUM 162 130 56 12
LEVETIRACETAM 160 98 57 130
TRIAMTERENE-HCTZ 158 121 58 37
NYSTATIN 158 135 58 203
BUSPIRONE HCL 156 75 60 125
PREDNISONE 155 138 61 40
LYRICA 149 109 62 52
DESONIDE 147 118 63 303
CIPROFLOXACIN HCL 147 135 63 49
METOCLOPRAMIDE HCL 146 95 65 102
METHOCARBAMOL 142 88 R 66 84
KLOR-CON M20 137 114 67 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 137 97 67 88
SEROQUEL 137 110 67 172
CYMBALTA 136 103 70 51
OXYBUTYNIN CHLORIDE 135 117 71 148
DIOVAN 132 117 72 55
PHENYTOIN SODIUM EXTENDED 131 72 73 128
METHADONE HCL 131 42 S2 73 127
CYCLOBENZAPRINE HCL 124 68 R 75 42
ALENDRONATE SODIUM 123 103 76 44
GLIPIZIDE 122 119 77 74
IBUPROFEN 119 103 78 93
SPIRONOLACTONE 119 100 78 53
MONOJECT INSULIN SYRINGE 116 98 80 374
MEGESTROL ACETATE 116 114 R 80 161
RIVASTIGMINE 116 116 80 280
TORSEMIDE 116 96 80 114
DILTIAZEM 24HR CD 113 87 84 138
MECLIZINE HCL 108 98 85 83
PROAIR HFA 105 53 86 62
LEVOFLOXACIN 102 82 87 76
LEXAPRO 101 77 88 219
ADVAIR DISKUS 101 97 88 68
PAROXETINE HCL 100 72 90 69
OLANZAPINE 100 53 90 191
LEVEMIR 99 93 92 198
ACTOS 99 68 92 144
DOXYCYCLINE HYCLATE 93 74 94 103
LANSOPRAZOLE 93 66 94 184
RANITIDINE HCL 93 61 94 39
CEFUROXIME 92 71 97 147
ZETIA 91 64 98 94
INSULIN SYRINGE 91 45 98 80
OXYCONTIN 91 42 S2 98 165
NAPROXEN 89 66 101 100
AMIODARONE HCL 89 68 101 139
HUMULIN 70-30 86 59 103 106
AMLODIPINE BESYLATE-BENAZEPRIL 86 35 103 50
GLYBURIDE 85 68 R 105 101
DIVALPROEX SODIUM ER 85 69 105 216
JANUVIA 84 66 107 85
AGGRENOX 84 66 107 233
SINGULAIR 84 63 107 73
GENERLAC 83 63 110 246
CELEBREX 83 68 110 89
KLOR-CON M10 82 61 112 168
IPRATROPIUM-ALBUTEROL 82 62 112 214
OXYCODONE-ACETAMINOPHEN 81 49 S2 114 187
HYDROXYZINE HCL 78 71 R 115 155
RAMIPRIL 77 61 116 70
NITROFURANTOIN MONO-MACRO 76 71 117 247
BACLOFEN 73 45 118 153
FOSINOPRIL SODIUM 73 60 118 112
GEMFIBROZIL 72 34 120 104
BRIMONIDINE TARTRATE 71 66 121 398
LATANOPROST 71 65 121 287
AMOX TR-POTASSIUM CLAVULANATE 66 47 123 135
BYSTOLIC 65 43 124 118
DETROL LA 64 61 125 215
PREMARIN 63 50 R 126 110
PRIMIDONE 62 39 127 199
TRIAMTERENE-HYDROCHLOROTHIAZID 62 43 127 162
BENAZEPRIL HCL 62 62 127 59
FLUCONAZOLE 61 45 130 111
COLCRYS 61 39 130 131
CARISOPRODOL 61 0 R 130 67
PHENYTOIN 61 51 130 327
TOPIRAMATE 61 25 130 145
LOSARTAN-HYDROCHLOROTHIAZIDE 61 57 130 33
BUPROPION XL 60 51 136 177
TIMOLOL MALEATE 59 34 137 379
AZITHROMYCIN 58 44 138 38
TRICOR 58 32 138 152
FENOFIBRATE 58 28 138 63
IRBESARTAN 56 48 141 304
TRIAMCINOLONE ACETONIDE 56 48 141 154
MORPHINE SULFATE ER 55 29 S2 143 141
CARBIDOPA-LEVODOPA 55 54 143 124
NITROSTAT 55 27 143 244
NOVOLIN 70-30 54 47 146 164
FLUOXETINE HCL 54 44 146 65
HYDRALAZINE HCL 54 27 146 54
DICYCLOMINE HCL 53 40 149 213
ISOSORBIDE MONONITRATE ER 52 52 150 60
CAPTOPRIL 51 32 151 262
TRAVATAN Z 50 50 152 315
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.